nicergoline has been researched along with thromboxane b2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boismare, F; Chartrel, N; Clabaut, M; Schrub, JC | 1 |
| Dechavanne, M; Ghazi, I; Guichardant, M; Lagarde, M | 1 |
2 other study(ies) available for nicergoline and thromboxane b2
| Article | Year |
|---|---|
Influence of an alpha-1-adrenoceptor antagonist, nicergoline, on placental prostanoid production in streptozotocin-induced diabetic pregnant rats.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenergic alpha-Antagonists; Animals; Diabetes Mellitus, Experimental; Dinoprostone; Ergolines; Fatty Acids; Female; Insulin; Nicergoline; Placenta; Pregnancy; Pregnancy in Diabetics; Prostanoic Acids; Rats; Rats, Inbred Strains; Thromboxane B2 | 1990 |
Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospholipids.
Topics: Arachidonic Acids; Blood Platelets; Ergolines; Humans; In Vitro Techniques; Nicergoline; Phospholipases; Phospholipids; Platelet Aggregation; Prostaglandins E; Prostaglandins F; Thromboxane B2 | 1980 |